476 EDTA Chelation Therapy References, Page 1 of 2
1-100
-
Ahrens FA and Aronson AL: A comparative study of the toxic effects of calcium and chromium chelates of ethylenediaminetetraacetate in the dog. Toxic Appl Pharmac 18:10, 1971.
-
Ahrens FA and Aronson AL: Toxicity of calcium ethylenediaminetetraacetate in dogs. Fed Proc Fedn Am Soc Exp Biol 27:1401, 1968.
-
Adams WJ and McGee CT: Chelation therapy: a survey of treatment outcomes and selected socio-medical factors. J Adv Med 5(3):189, 1992.
-
Agerty HA: Lead poisoning in children. Medical Clinics of North America. (36):1587, 1952.
-
Ahrens FA and Aronson AL: Comparative study of the toxic effects of calcium chelates of ethylenediaminetetraacetate in the dog. Tox Appl Pharmocol (18)1:10 1971.
-
Alfthan G, Pikkarainen J, Huttunen JK, Puska P: Association between cardiovascular death and myocardial infarction and serum selenium in a matched- pair longitudinal study. Lancet 2(8291):175, 1982.
-
Allen AC: The Kidney Grune and Stratton, N.Y., p. 329, 1962.
-
AItmann J, Wakim KG and Winkelmann RK: Effects of edathamil disodium on the kidney. J Invest Dermatol (38): 215, 1962.
-
Angle CR and McIntire MS: Lead poisoning during pregnancy. Fetal tolerance of calcium disodium edetate . Am J Dis Child 108:436, 1964.
-
Ames BN: Dietary carcinogens and anticarcinogens. Science 221:1256, 1983.
-
Aronov DM: First experience with the treatment of atherosclerosis patients with calcinosis of the arteries with trilon-B (disodium salt of EDTA). (Russ, Moscow) Klin Med 41:19, 1963.
-
Aronson AL and Ahrens FA: The mechanism of renal transport and excretion of ethylenediaminetetraacetate with interspecies comparison. Toxic Appl Pharmac 18:1, 1971.
-
Aronson AL and Hammond PB: Effect of two chelating agents on the distribution and excretion of lead. J Pharmacol Exp Ther 146:241-251, 1964.
-
Aronson AL, Hammond PB and Strafuss AC: Studies with calcium ethylenediaminetetraacetate in calves; toxicity and use in bovine lead poisoning. Toxicol Appl Pharmacol 12:337-349, 1968.
-
Atherosclerosis and auto oxidation of cholesterol, editorial. Lancet ii:964, 1980.
-
Batchelor TM, McCall M and Mosher RM: Potassium dieresis induced by edathamil disodium. JAMA 187:305, 1964.
-
Bates GW, Billups C and Saltman P: The kinetics and mechanism of iron (III) exchange between chelates and transferrin. II. The presentation and removal with ethylenediaminetetraacetate. J Biol Chem 242:2816, 1967.
-
Batuman V, Landy E, Maesaka JK, Wedeen RP: Contribution of lead to hypertension with renal impairment .N EngI J Med 309(1):17, 1983.
-
Batuman V, Maesaka JK, Haddad B, et al: The role of lead in gout nephropathy. N.E.J.M. (304)9:520, 1981.
-
Bauer RO, Rullo FR, Spooner C, et al: Acute and subacute toxicity of ethylene diamine tetraacetic acid (EDTA) salts. Federation Proc (11): 321, 1952.
-
Bechtel JT, White JE and Estes EH Jr: The electrocardiographic effects of hypocalcemia induced in normal subjects with edathamil disodium. Circulation 13:837, 1956.
-
Belknap EL: EDTA in the treatrment of lead poisoning. Indust Med & Surg (21):305,1952.
-
Berkman N, Michaeli Y, Or R and Eldor A: EDTA dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature. Am J Hematol 36:195, 1991.
-
Bessman SP, Ried H and Rubin M: Treatment of lead encephalopathy with calcium disodium versenate. Ann Med Soc DC 21:312, 1952.
-
Bhat RK, et a!: Trace elements in hair and environmental exposure. Sci Total Environ 22(2):169, 1982.
-
Birk RE and Rupe CE: The treatment of systemic sclerosis with disodium EDTA, pyridoxine and reserpine. Henry Ford Hosp Med Bull 14:109, 1966.
-
Birk RE and Rupe CE: Systemic sclerosis. Fourteen cases treated with chelation (disodium EDTA) and/or pyridoxine, with comments on the possible role of altered tryptophan metabolism in pathogenesis. Henry Ford Hosp Med Bull 10:523, 1962.
-
Bjorksten J: The cross-linkage theory of aging as a predictive indicator. Rejuvenation 8:59, 1980.
-
Bjorksten J: Possibilities and limitations of chelation as a means for life extension. Rejuvenation 8:67, 1980.
-
Blake DR, Hall ND, Bacon PA, Dieppe PA, Halliwell B, Gutteridge JM: The importance of iron in rheumatoid disease. Lancet :1142, 1981.
-
Blake DR, Hall ND, Bacon PA, Dieppe PA, Halliwell B, Gutteridge JMC: Effect of a specific iron chelating agent on animal models of inflammation. Ann Rheum Dis 42:89, 1983.
-
Bland JS: The utility of hair analysis: A reevaluation. J Holistic Medicine 5(1):16, 1983.
-
Blumer W, Reich T: Leaded gasoline – cause of cancer. Environmental International 3:465, 1980.
-
Blumer W and Cranton EM: Ninety percent reduction in cancer mortality after chelation therapy with EDTA. J Adv Med 2:183, 1989.
-
Bolick LE and Blankenhorn DH: A quantitative study of coronary arterial calcification. Am J Path 39:511, 1961.
-
Boyle AJ, Jasper JJ, McCormick H, et al: Studies in human and induced atherosclerosis employing – (EDTA). Bull Swiss Acad Med Sci 13:408, 1957.
-
Boyle M, Wegria R, Cathcart RT, et al: Effects of intravenous injections of nicotine on the circulation. Am Heart J (34): 65, 1947.
-
Boyle AJ, Clarke NE, Mosher RE, McCann DS: Chelation therapy in circulatory and sclerosing diseases. Fed Proc 20(3) (Part II) (suppl 10):243-257, 1961.
-
Boyle AS, Mosher LE, McCann DS: Some in vivo effects of chelation-I: Rheumatoid arthritis. J Chronic Dis 16:325, 1963.
-
Brachet P and Klein C: Cell response to CAMP during aggregation phase of Dictyostelium discoideum. Comparison of the inhibitory effects of progesterone and the stimulatory action of EDTA and ionophore A23187. Differention (8)1:1, 1977.
-
Brecher A: Bye-Bye Bypass: The Truth About Chelation Therapy. Troup, Texas, Health Savers Press, 1989.
-
Brien TG and Fay J: [51Cr] EDTA biological half life as an index of renal function. J Nuc Med. (13) 5:339, 1972.
-
Brecher A: Bye-Bye Bypass: The Truth About Chelation Therapy. Troup, Texas, Health Savers Press, 1989.
-
Brucknerova O, Tulacek J and Krojzl O: Chelates in the treatment of obliterating arteriopathies. Vnitrni Lek 14:841, 1968.
-
Brucknerova 0 and Malinovska V: First clinical experience with combined treatment with chelation III and glucagon in ischemic disease of the lower extremities, Cas Lek Cas 119:814,1980.
-
Brucknerova 0, Tulacek J: Chelates in the treatment of occlusive atherosclerosis. (Czech, Praha) Vnitr Lek 18:729, 1972.
-
BurckhardIt P, Boillat AM, Reudi B, et al: Effect of parathyroid hormone immunoheterogeneity. Schweiz Med Wochenschr (105) 50:1692, 1975.
-
Butler AM: Use of calcium ethylenediaminetetraacetate in treating heavy-metal poisoning. Arch Indust Hyg Occupat Med 7:136, 1952.
-
Butterfield JD, McGraw CP: Free radical pathology. Stroke 9(5):443, 1978.
-
Calcium disodium edetate and disodium edetate. Drugs for human use; drug efficacy study implementation. Department of Health, Education, and Welfare. Food and Drug Administration. Federal Registrar 35 F.R. 437, 1970.
-
Casdorph HR: Chelation therapy: a reappraisal. N Z Med J 66, 1983.
-
Casdorph HR: EDTA chelation therapy, efficacy in arteriosclerotic heart disease. J Holistic Medicine 3(1):53, 1981.
-
Casdorph HR: EDTA chelation therapy II, efficacy in brain disorders. J Holistic Medicine 3(2):101, 1981.
-
Casdorph HR, Farr CH: EDTA chelation therapy Ill: Treatment of peripheral arterial occlusion, an alternative to amputation. J Holistic Medicine 3(1):3, 1983.
-
Cashion WR Jr: What about chelation? Texas Medicine 80:6, 1984.
-
Castellino N and Aloj S: Effects of calcium sodium ethylenediaminetetra-acetate on the kinetics of the distribution and excretion of lead in the rat. Brit J Indust Med 22:172, 1965.
-
Catsch A: Radioactive metal mobilization. Fed Proc 20 (Suppl 10):206, 1961.
-
Catsch A and Harmuth-Hoene AE: Pharmacology and therapeutic applications of agents used in heavy metal poisoning. Pharmac Ther. A, (1):1, 1976.
-
Chaitlow L: Chelation Therapy: The Revolutionary Alternative to Heart Surgery. San Francisco, Thorsons SF, 1991.
-
Chantler C and Barratt TM: Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child 47:613, 1972.
-
Chantler C, Garnett ES, Parsons V and Veall N: Glomerular filtration rate measurement in man by the single injection method using 51Cr-EDTA. Clin Sci 37:169, 1969.
-
Chappell LT and Stahl JP: The correlation between EDTA chelation therapy and improvement in cardiovascular function: a meta-analysis. J Adv Med 6(3):139, 1993.
-
Chappell LT, Stahl JP and Evans R: EDTA chelation treatment for vascular disease: a meta-analysis using unpublished data. J Adv Med 7(3),131, 1994.
-
Chappell LT, Janson M, Whitaker J: A challenge to cardiovascular surgeons. J Adv Med (In Press)
-
Chappell LT: Chelation therapy, smoking and health care costs (Letter). J Adv Med 7:107, 1994.
-
Chappell LT: EDTA chelation therapy should be more commonly used in the treatment of vascular disease. Alternative Therapies Health Med 1:53, 1995.
-
Chappell LT, Miranda R, Rubin M, Carter JP and Trowbridge J: Chelation therapy (Letter). Circulation 92:1350, 1995.
-
Chelation therapy (Diagnostic and therapeutic technology assessment). JAMA 250:672, 1983.
-
Chelation therapy: a second look. The Harvard Medical School Health Letter, IX:1, 1984.
-
Chelation Therapy Clinic: Chelation therapy – the treatment of choice for relief from and prevention of, cardiovascular and age-related diseases. Aukland, New Zealand, The Chelation Therapy Clinic, 1987.
-
Chelation therapy. Resolution: 66 (I-84). AMA House of Delegates. 1984.
-
Chelation therapy. Report of the Council on Scientific Affairs. Report F (I-84). AMA House of Delegates. 1984.
-
Chelation therapy – An informal summary. Department of Health & Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute. Bethesda, Maryland. June 1992.
-
Chen IW, Park HM, King LR, Bahr GK and Goldsmith RE: Radioimmunoassay of parathyroid hormone: peripheral plasma immunoreactive parathyroid hormone response to ethylenediaminetetraacetate. J Nucl Med 15:763, 1974.
-
Cheraskin E, Wussow DG, McDonagh EW and Rudolph CJ: Effect of EDTA chelation and supportive multivitamin/trace mineral supplementation with and without physical activity on the heart rate. J InternAcadof Prev Medi 8(6):5, 1984.
-
Chisolm JJ Jr: Chelation therapy in children with subclinical plumbism. Pediatrics 53:441, 1974.
-
Chisolm JJ Jr: The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood. J Pediat 73:1, 1968.
-
Clarke NE Sr, Clarke NE Jr, Mosher RE: Treatment of occlusive vascular disease with disodium ethylene diamine tetraacetic acid (EDTA). The Amer J of the Med Sci June:732, 1960.
-
Clarke NE, Clarke CN, and Mosher RE: Treatment of angina pectoris with disodium ethylene diamine tetra-acetic acid. Am J of Med Sci 232:654, 1956.
-
Clarke NE Sr: Atherosclerosis, occlusive vascular disease and EDTA. Am J Cardiol 6(2):233, 1960.
-
Clarke NE, Clarke CN, Mosher RE: The “in vivo” dissolution of metastatic calcium: An approach to atherosclerosis. Am J Med Sci 229:142,1955.
-
Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31, 1976.
-
Cohen SH, Gong JK and Fishler MC: Ethylene diamine tetraacetic acid (EDTA) treatment of internal radioactive contamination. Nucleonics (11)1: 56, 1953.
-
Cohen S, Weissler AM and Schoenfeld CD: Antagonism of the contractile effect of digitalis by EDTA in the normal human ventricle. Am Heart J 69:502, 1965.
-
Cook JD, Finch CA, Smith NJ: Evaluation of the iron status of a population. Blood 48(3):449, 1976.
-
Couric JM: Chelation therapy overdone. FDA Consumer 16:28. 1982.
-
Cranton EM and Frackelton JP: Negative Danish Study of EDTA chelation biased. Townsend Letter for Doctors July, 604-605, Letter, 1992.
-
Cranton EM: Critique of the American Medical Association’s published position on hair analysis. J Holistic Medicine 8(1);47, 1986.
-
Cranton EM, Bland JS, Chatt A, Krakovitz R, Wright JV: Standardization and interpretation of human hair for elemental concentrations. J Holistic Medicine 1982;4:10, 1982.
-
Cranton EM: Update on hair analysis in clinical medicine. J Holistic Medicine 7(2):120,1986.
-
Cranton EM and Frackelton JP: The current status of EDTA chelation therapy in the treatment of occlusive arterial disease. Journal of Holistic Medicine 4: 24, 1982.
-
Cranton EM: Protocol of the American College of Advancement in Medicine for the safe and effective administration of EDTA chelation therapy. J Adv Med 2:269, 1989.
-
Cranton EM: A textbook on EDTA chelation therapy. J Adv Med 2:1-416, 1989.
-
Cranton EM and Frackelton JP: Free radical pathology in age associated diseases; treatment with EDTA chelation, nutrition and antioxidants. J Holistic Med 6: 1, 1984.
-
Cranton EM: Kidney effects of ethylene diamine tetraacetic acid (EDTA): A literature review. J Holistic Medicine 4:152, 1982.
-
Cranton EM: The current status of EDTA chelation therapy, editorial. J Holistic Med 7(1):3, 1985.
-
Cranton EM, Brecher A: Bypassing Bypass: The New Technique of Chelation Therapy ed 2 ,Medex Publishers Inc, P.O. Box 44, Trout Dale, VA 24378, 1989.
-
Craven, PC and Morelli HF: Chelation therapy. West J Med, 122:277, 1975.
-
Curran CL: Metal chelating agents and hepatic cholesterol synthesis. Proc Soc Exper Biol & Med 88:101, 1955.
-
Darwish NM and Kratzer FH: Metabolism of ethylenediaminetetraacetic acid (EDTA) by chickens. J Nutr 86:187, 1965.
​101-200
-
David 0, Hoffman SP, Sverd J, Clark J, Voeller K: Lead and hyperactivity, behavioral response to chelation: A pilot study. Am J Psychiatry 133:1155, 1976.
-
Davis FA, Becker FO, Michael JA and Sorensen E: Effect of intravenous sodium bicarbonate disodium EDTA and hyperventilation on visual and oculomotor signs in multiple sclerosis. J Neurol Neuro-surg Psychiat 33:723, 1970.
-
Davis PS and Deller DJ: Effect of orally administered chelating agents EDTA, DTPA and fructose on radioiron absorption in man. Aust Ann Med 16:70, 1967.
-
Davis H and Moe PJ: Favorable response of calcinosis universalis to edathamil disodium. Pediatriacs 24:780, 1959.
-
Deftos LJ, Goodman AD, Engleman K, et al: Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma. Metab Clin Med. (20)4: 428, 1971.
-
Del Maestro RF: An approach to free radicals in medicine and biology. Acta Physiol Scand 492(suppl):153, 1980.
-
Demopoulos HB: The basis of free radical pathology. Fed Proc 32:1859, 1973.
-
Demopoulos, HB: Control of free radicals in the biologic systems. Fed Proc 32: 1903, 1973.
-
Demopoulos HB, Pietronigro DD, Flamm ES, Seligrnan ML: The possible role of free radical reactions in carcinogenesis. Journal of Environmental Pathology and Toxicology 3:273, 1980.
-
Demopoulos HB, Flamm ES, Pietronigro DD, Seligman ML: The free radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol Scand 492(suppl):91, 1980.
-
Demopoulus HB: Molecular oxygen in health and disease. Presented AAMP Tenth Annual Spring Meeting May 21, 1983, Los Angeles, California.
-
Demopoulos HB, Peitronigro DD, Seligman ML: The development of secondary pathology with free radical reactions as a threshold mechanism. J Am Coll Tox 2(3):173, 1983.
-
Deucher DP: EDTA chelation therapy: an antioxidant strategy. J Adv Med 1:182, 1988.
-
Deucher GP: Heay metals, chelation therapy, free radicals and human disease. Angiologie, Octobre 1987.
-
Diagnostic and therapeutic technology assessment: chelation therapy. JAMA 250:672,1983.
-
Dix T: Metabolism of polycyclic aromatic hydrocarbon derivatives to ultimate carcinogens during lipid peroxidation. Science 221:77, 1983.
-
Donald GF, Hunter GA, Roman W and Taylor AEJ: Current concepts of cutaneous porphyria and its treatment with particular reference to the use of sodium calcium-edetate. Brit J Derm 82:70, 1970.
-
Donsbach KW: Chelation Therapy; Has the Plug Been Pulled on Our Biggest Killer? Huntington Beach, CA, International Institute of Health, 1981.
-
Doolan PD, Schwartz SL, Hayes JR, Mullen JC, Cummings NB: An evaluation of the nephrotoxicity of ethylene diamine tetraacetate and diethylene trinenine pentaacetate in the rat. Toxicol AppI Pharmocol 10:481, 1967.
-
Dormandy Tl: Free-radical reaction in biological systerms. Ann R Coll Surg Engl 62:188, 1980.
-
Dormandy TL: Free-radical oxidation and antioxidants, Lancet i:647, 1978.
-
Dormandy TL: An approach to free radicals. Lancet 1983; ii:1010, 1983.
-
Dudley HR, Ritchie A, Schilling A, et al: Pathologic changes associated with the use of sodium ethylene diamine tetraacetate in the treatment of hypercalcemia. NEJM (252): 331, 1955.
-
EDTA chelation therapy for arteriosclerotic heart disease. Medical Letter 23,1981.
-
EDTA chelation: a rebuttal. J Adv Med 5:3, 1992.
-
EDTA chelation therapy for atherosclerotic cardiovascular disease. Medical Letter 36:48 l994.
-
Eliot RS and Blout SG Jr: Calcium, chelates and digitalis. A clinical study. Am Heart J 62:7, 1961.
-
Elwood PC, Benjamin IT, Waters WE, Sweetnam PM: Mortality and anemia in women. Lancet :891, 1974.
-
Emmerson BT: Chronic lead nephropathy. The diagnostic use of calcium EDTA and the association with gout. Australian Ann Med 12: 310, 1963.
-
Emmerson BT and Thiele BR: Calcium versenate in the diagnosis of chronic lead nephropathy. Med J Aust (1): 243,1960.
-
Ericson JE, Shirahata H, Patterson CC: Skeletal concentrations of lead in ancient Peruvians. N Engl J Med 300:946, 1979.
-
Estep HL, Gardner CT Jr, Taylor JP, Minott A and Tucker HStG Jr: Phosphate excretion patterns following intravenous injection of ethylenediaminetetraacetate ((EDTA). J Clin Endocr 25:1385, 1965.
-
Favre HR and Wing AJ: Simultaneous 51Cr edetic acid, inulin, and endogenous creatinine clearances in 20 patients with renal disease. Brit Med J 1:84, 1968.
-
Feigen RD, Shannon DC, Reynolds SL, Shapiro LW and Connelly JP: Lead poisoning in children. Clin Pediat 4:38, 1965.
-
Fine SD: Calcium disodium edetate and disodium edetate. Drugs for human use; Drug efficacy study implementation. Fed Reg (35)8: Jan. 13, 1970.
-
Fink CW and Baum J: Treatment of calcinosis universalis with chelating agents. Am J Dis Child 105:390, 1963.
-
Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J: Free radicals in cerebral ischemia. Stroke 9(5):445,1978.
-
140 Flynn DM: 5-year controlled trial of chelating agents in treatment of thalassaemia major. Arch Dis Child 48:829, 1973.
-
Flytlie K and Hancke C: Letter to the editor: EDTA manipulated. J Adv Med 6(1):53, 1993.
-
Foote CS: Chemistry of singlet oxygen VII. Quenching by beta carotene. J Am Chem Soc 90:6233, 1968.
-
Foreman H: Pharmacology of some useful chelating agents. In Seven MJ and Johnson LA (eds): Metal-Binding in Medicine. Philadelphia, JB Lippincott, 1960.
-
Foreman H: The use of chelating agents for excelerating excretion of radioelements. J Am Pharm Assoc (42): 629, 1953.
-
Foreman H: Toxic side effects of ethylenediaminetetraacetic acid. J Chron Dis (16):319, 1963.
-
Foreman H: Summary remarks by the chairman. [Proceedings of a conference on biological apects of metal-binding.] Fed Proc 20 (Suppl 10):257, 1961.
-
Foreman H: Use of chelating agents in treatment of metal poisoning with special emphsis on lead). Fed Proc 20 (Suppl 10):191, 1961.
-
Foreman H, Finnegan C and Lushbough C: Nephrotoxic hazard from uncontrolled edathamil calcium disodium therapy. JAMA (160): 1042, 1956.
-
Foreman H, Vier M and Magee M: The metabolism of C14 labeled ethylenediaminetetraacetic acid in the rat. J Biol Chem 203:1045, 1953.
-
Foreman H, Finnegan C and Lushbaugh CC: Nephrotoxic hazard from uncontrolled edathamil calcium-disodium therapy. JAMA 160:1042, 1956.
-
Foreman H, Hardy H, Shipman T, et al: Use of calcium ethylenediaminetetraacetate in cases of lead intoxication. Ama Archiv Indust Hyg Occup Med (7): 148, 1953.
-
Foreman H and Trujillo T: Metabolism of carbon 14 labeled ethylenediaminetetraacetic acid in human beings. J Lab Clin Med (43): 566, 1954.
-
Forssman O and Nordqvist P: The action in vitro and in vivo of sodium versenate on the phagocytic activity of neutrophile leukocytes. Acta Haemat 31:289, 1964.
-
Frackelton JP, Cranton EM: Iron and copper supplementation with EDTA chelation therapy. J Holistic Med 8(1):63, 1986.
-
Frackelton JP: Monitoring renal function during EDTA chelation therapy. J Holistic Med 8(1):33, 1986.
-
Friedel W, Schulz FH Schroder L: Therapy of atherosclerosis through mucopolysaccarides and EDTA (ethylene diamine tetraacetic acid). (German) Deutsch Gesundh 20:1566, 1965.
-
Fromke VL, Lee MY and Watson CJ: Porphyrin metabolism during Versenate® therapy in lead poisoning. Intoxication from an unusual source. Ann Intern Med 70:1007, 1969.
-
Fuleihan FJD, Kurban AK, Abboud RT, Beidas-jubran N and Farah FS: An objective evaluation of the treatment of systemic scleroderma with disodium EDTA, pyridoxine and reserpine. Brit J Derm 80:184, 1968.
-
Gaby AR: Nutritional factors in cardiovascular disease. J Holistic Medicine 5(2):l07, 1983.
-
Gerstenblith G, Ouyang P, Achuff S, et al: Nifedipine in unstable angina: A double-blind, randomized trial. NEJM (306)15: 885, 1982.
-
Ghiringhelli L and Respighi E: The tubular reabsorption of phosphorus during the test of parathyroid stimulation by versenate (test of Kaiser &Ponsold). Atti Acad Med Lombarda 18:191, 1963.
-
Ghiringhelli L, Marinoni E and Respighi E: Study of the parathyroid function by means of the Kaiser &Ponsold test in a group of thyroidectomized patients. Minerva Med 54:2829, 1963.
-
Gibbons HL: Edetate disodium calcium, calcium-channel blockers, and heart disease. JAMA 246:1728, 1981.
-
Godfrey ME: EDTA chelation as a treatment of arteriosclerosis .N Z Med J 93:199, 1990.
-
Godfrey ME, Frackleton JP and Chappell LT: Chelation therapy for intermittent claudication (Letter). Z Med J 107:495, 1994.
-
Godfrey ME, Agnihotri R and Strauss A: Chelation and arteriosclerosis. N Z Med J 101(838):21, 1988.
-
Goetzl EJ: Oxygenation products of arachidonic acid as mediators of hypersensitivity and inflammation. Med Clin North Am 65(4):809, 1981.
-
Godfrey ME, Frackleton JP and Chappell LT: Chelation therapy for intermittent claudication (Letter). Z Med J 107:495, 1994.
-
Goodman and Gillman’s Pharmacological Basis of Therapeutics: Heavy Metals and Heavy Metal Antagonists. 6:1615, 1980
-
Gordon T, Castelli WP, Hjortland MC, et al: High density lipoprotein as a protective factor against coronary heart disease. The Framington Study. Am J Med (62): 707, 1977.
-
Gordon GB, Vance RB: EDTA chelation therapy for atherosclerosis: History and mechanisms of action. Osteopathic Annals 4:38, 1976.
-
Gordon GF: Oral chelation with EDTA. J Holistic Medicine 8(1):79, 1986.
-
Gordon T, Kannel WB, Hjortland MC, McNamara PM: Menopause and coronary heart disease. The Framingham Study. Am Intern Med 89:157, 1978.
-
Gotto AM Jr: Chelation therapy in 1984. Texas Medicine, 80:36, 1984.
-
Gould RG: Metals and chelating agents in relation to atherosclerosis. Fed Proc 20 (Suppl 10):252, 1961.
-
Grier MT and Meyers DG: So much writing, so little science: A review of 37 years of literature on edetate sodium chelation therapy. Ann Pharmacother 27:1504, 1993.
-
Grumbles LA: Radionuclide studies of cerebral and cardiac arteriography before and after chelation therapy. New Horizons in Holistic Health II (Symposium). Chicago, May 27, 1979.
-
Guldager B, Jelnes R, Jorgenson SJ, et al: EDTA treatment of intermittent claudication – a double-blind placebo-controlled study. J Intern Med 231:261, 1992.
-
Gutteridge JMC, Rowley DA, Halliwell B: Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Biochem J 206:605, 1982.
-
Gutteridge JMC, Rowley DA, Halliwell B and Westermarck T: Increased non-protein-bound iron and decreased protection against superoxide radical damage in cerebrospinal fluid from patients with neuronal ceroid lipofuscinoses. Lancet ii:459,1982.
-
Halstead BW: The Scientific Basis of EDTA Chelation Therapy. Colton, CA, Golden Quill Publishers, Box 1278, Coltotn, CA 92324,1979.
-
Hancke C and Flytlie K: Benefits of EDTA chelation therapy in arteriosclerosis: a retrospective study of 470 patients. J Adv Med 6(3):161,1993.
-
Hancke C and Flytlie K: Manipulation with EDTA. Ugeskr Laeger 154:2213, 1992.
-
Hansotia P, Peters H, Bennett M and Brown R: Chelation therapy in Wegener’s granulomatosis. Treatment with EDTA. Ann Otol 78:388, 1969.
-
Hardy HL: Clinical experience with the use of calcium disodium ethylenediaminetetraacetate in the therapy of lead poisoning. Fed Proc 20 (Suppl 10):252, 1961.
-
Harman D: The aging process. Proc Natl Acad Sci USA 78:7124, 1981.
-
Harper JW andGordon GF: Reprints of Medical Literature on Chelation Therapy. Los Angeles, American Academy of Medical Preventics, 1975.
-
Hardy HL: Clinical experience with the use of calcium disodium ethylenediaminetetraacetate in the therapy of lead poisoning. Fed Proc 20 (Suppl 10):252, 1961.
-
Hatano S, Nishi Y, Usui T: Copper levels in plasma and erythrocytes in healthy Japanese children and adults. Am J Clin Nutr 35:120, 1982.
-
Haumont S and Vincent J: Action of calcium versenate on lead fixed in vivo in compact bone. Exp Cell Res 18:404, 1959.
-
Hausmann E: Changes in plasma phosphate concentration on infusion of calcium gluconate or Na2EDTA. Proc Soc Exp Biol Med 134:182, 1970.
-
Hay DR: Chelation therapy. N Z Med J 101(841):122, 1988.
-
Hay DR: Chelation therapy. N Z Med J 101(845):246, 1988.
-
Heath DA, Knapp MS and Walker WHC: Comparison between inulin and 51Cr-labelled edetic acid for the measurement of glomerular filtration-rate. Lancet 2:1110, 1968.
-
Hegsted DM: Major minerals. Section A. Calcium and phosphorus. In: RS Goodheart and ME Shields (Eds.). Modern Nutrition in Health and Disease. Lea and Febiger, Phila., p. 266, 1974.
-
Heller J and Vostal J: Renal excretion of calcium-disodium-ethylenediamine-tetraacetic acid – a new tubular secretory mechanism? Experientia 20:99, 1964.
-
Herd JK and Vaughan JH: Calcinosis universalis complicating dermatomyositis – its treatment with Na2EDTA. Report of two cases in children. Arthritis Rheum 7:259, 1964.
-
Hess ML, Manson NH, Okabe E: Involvement of free radicals in the pathophysiology of ischemic heart disease. Can J Physiol Pharmacol 60(11):1382, 1982.
-
Hjortland MC, McNamara PM, Kannel WB: Some atherogenic concomitants of menopause:The Framingham Study. Am J Epidemiol 103:304, 1976.
-
Holland JF, Danielson E and Sahagian-Edwards A: Use of EDTA in hypercalcemic patients. Proc Soc Exp Biol Med 84:359, 1953.
-
HoIm LW: The use of calcium disodium salt of Versene in heavy-metal poisoning of livestock. Proc Am Vet Med Assoc (48): 33, 1954.
-
Hösli P: Therapy of scleroderma with the disodium salt of ethylenediaminetetraacetic acid; a contribution to the toxicology of versenate. Part I. Arzneimittelforschung 10:65, 1960.
​​